Logo image of DMRE.DE

DEMIRE DT MTS REAL ESTATE AG (DMRE.DE) Stock Fundamental Analysis

Europe - FRA:DMRE - DE000A0XFSF0 - Common Stock

0.44 EUR
+0.01 (+3.29%)
Last: 11/17/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DMRE. DMRE was compared to 71 industry peers in the Real Estate Management & Development industry. Both the profitability and financial health of DMRE have multiple concerns. DMRE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year DMRE has reported negative net income.
DMRE had a positive operating cash flow in the past year.
In multiple years DMRE reported negative net income over the last 5 years.
DMRE had a positive operating cash flow in 4 of the past 5 years.
DMRE.DE Yearly Net Income VS EBIT VS OCF VS FCFDMRE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

DMRE has a worse Return On Assets (-11.70%) than 83.10% of its industry peers.
With a Return On Equity value of -60.37%, DMRE is not doing good in the industry: 84.51% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -11.7%
ROE -60.37%
ROIC N/A
ROA(3y)-8.15%
ROA(5y)-4.1%
ROE(3y)-34.25%
ROE(5y)-18.11%
ROIC(3y)N/A
ROIC(5y)N/A
DMRE.DE Yearly ROA, ROE, ROICDMRE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

DMRE has a Gross Margin (56.41%) which is comparable to the rest of the industry.
DMRE's Gross Margin has declined in the last couple of years.
DMRE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.01%
GM growth 5Y-2.77%
DMRE.DE Yearly Profit, Operating, Gross MarginsDMRE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

2

2. Health

2.1 Basic Checks

DMRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DMRE remains at a similar level compared to 1 year ago.
Compared to 5 years ago, DMRE has less shares outstanding
The debt/assets ratio for DMRE has been reduced compared to a year ago.
DMRE.DE Yearly Shares OutstandingDMRE.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
DMRE.DE Yearly Total Debt VS Total AssetsDMRE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of -0.10, we must say that DMRE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.10, DMRE is not doing good in the industry: 80.28% of the companies in the same industry are doing better.
The Debt to FCF ratio of DMRE is 32.68, which is on the high side as it means it would take DMRE, 32.68 years of fcf income to pay off all of its debts.
DMRE has a Debt to FCF ratio (32.68) which is in line with its industry peers.
A Debt/Equity ratio of 2.19 is on the high side and indicates that DMRE has dependencies on debt financing.
DMRE has a worse Debt to Equity ratio (2.19) than 83.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.19
Debt/FCF 32.68
Altman-Z -0.1
ROIC/WACCN/A
WACC3.66%
DMRE.DE Yearly LT Debt VS Equity VS FCFDMRE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.35 indicates that DMRE may have some problems paying its short term obligations.
DMRE has a Current ratio of 0.35. This is amonst the worse of the industry: DMRE underperforms 83.10% of its industry peers.
DMRE has a Quick Ratio of 0.35. This is a bad value and indicates that DMRE is not financially healthy enough and could expect problems in meeting its short term obligations.
DMRE's Quick ratio of 0.35 is on the low side compared to the rest of the industry. DMRE is outperformed by 74.65% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
DMRE.DE Yearly Current Assets VS Current LiabilitesDMRE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.23% over the past year.
DMRE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.04%.
DMRE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.11% yearly.
EPS 1Y (TTM)20.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.82%
Revenue 1Y (TTM)-24.04%
Revenue growth 3Y-7.1%
Revenue growth 5Y-4.11%
Sales Q2Q%-15.19%

3.2 Future

Based on estimates for the next years, DMRE will show a very strong growth in Earnings Per Share. The EPS will grow by 30.22% on average per year.
Based on estimates for the next years, DMRE will show a decrease in Revenue. The Revenue will decrease by -6.64% on average per year.
EPS Next Y16.67%
EPS Next 2Y33.85%
EPS Next 3Y30.22%
EPS Next 5YN/A
Revenue Next Year-16.82%
Revenue Next 2Y-10.9%
Revenue Next 3Y-6.64%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DMRE.DE Yearly Revenue VS EstimatesDMRE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
DMRE.DE Yearly EPS VS EstimatesDMRE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5

3

4. Valuation

4.1 Price/Earnings Ratio

DMRE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DMRE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DMRE.DE Price Earnings VS Forward Price EarningsDMRE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DMRE is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, DMRE is valued cheaply inside the industry as 88.73% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.04
EV/EBITDA 24.63
DMRE.DE Per share dataDMRE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as DMRE's earnings are expected to grow with 30.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.85%
EPS Next 3Y30.22%

0

5. Dividend

5.1 Amount

DMRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DEMIRE DT MTS REAL ESTATE AG

FRA:DMRE (11/17/2025, 7:00:00 PM)

0.44

+0.01 (+3.29%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-06 2025-11-06
Earnings (Next)03-18 2026-03-18/amc
Inst Owners0.77%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap47.42M
Revenue(TTM)71.98M
Net Income(TTM)-104.10M
Analysts82.86
Price Target1.22 (177.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)81.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-400%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-58.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.66
P/FCF 3.04
P/OCF 1.8
P/B 0.28
P/tB 0.28
EV/EBITDA 24.63
EPS(TTM)-0.99
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)0.14
FCFY32.86%
OCF(TTM)0.24
OCFY55.56%
SpS0.67
BVpS1.6
TBVpS1.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.7%
ROE -60.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.41%
FCFM 21.65%
ROA(3y)-8.15%
ROA(5y)-4.1%
ROE(3y)-34.25%
ROE(5y)-18.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.01%
GM growth 5Y-2.77%
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 2.19
Debt/FCF 32.68
Debt/EBITDA 18.44
Cap/Depr 17.02%
Cap/Sales 14.96%
Interest Coverage N/A
Cash Conversion 128.87%
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z -0.1
F-Score5
WACC3.66%
ROIC/WACCN/A
Cap/Depr(3y)135.54%
Cap/Depr(5y)384.35%
Cap/Sales(3y)19.79%
Cap/Sales(5y)28.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-31.82%
EPS Next Y16.67%
EPS Next 2Y33.85%
EPS Next 3Y30.22%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.04%
Revenue growth 3Y-7.1%
Revenue growth 5Y-4.11%
Sales Q2Q%-15.19%
Revenue Next Year-16.82%
Revenue Next 2Y-10.9%
Revenue Next 3Y-6.64%
Revenue Next 5YN/A
EBIT growth 1Y-1511.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year167.06%
EBIT Next 3Y38.74%
EBIT Next 5YN/A
FCF growth 1Y-75.79%
FCF growth 3Y-20.3%
FCF growth 5YN/A
OCF growth 1Y-68.16%
OCF growth 3Y-19.11%
OCF growth 5Y-5.51%

DEMIRE DT MTS REAL ESTATE AG / DMRE.DE FAQ

What is the ChartMill fundamental rating of DEMIRE DT MTS REAL ESTATE AG (DMRE.DE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to DMRE.DE.


Can you provide the valuation status for DEMIRE DT MTS REAL ESTATE AG?

ChartMill assigns a valuation rating of 3 / 10 to DEMIRE DT MTS REAL ESTATE AG (DMRE.DE). This can be considered as Overvalued.


How profitable is DEMIRE DT MTS REAL ESTATE AG (DMRE.DE) stock?

DEMIRE DT MTS REAL ESTATE AG (DMRE.DE) has a profitability rating of 1 / 10.


Can you provide the financial health for DMRE stock?

The financial health rating of DEMIRE DT MTS REAL ESTATE AG (DMRE.DE) is 2 / 10.